Os Therapies Incorporated (OSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Operating Expenses | 1,157 | 622 | 1,515 | 1,048 | 0 |
| Operating Income | -1,157 | -622 | -1,515 | -1,048 | N/A |
| Interest Expense | 307 | 1,353 | 990 | 799 | 0 |
| Other Income | -1 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -1,465 | -1,975 | -2,505 | -1,847 | 0 |
| Net Income Continuous | -1,465 | -1,975 | -2,505 | -1,847 | N/A |
| Net Income | $-1,465 | $-1,975 | $-2,505 | $-1,847 | $N/A |
| EPS Basic Total Ops | -0.43 | -0.38 | -0.47 | -0.18 | N/A |
| EPS Basic Continuous Ops | -0.42 | -0.37 | -0.47 | -0.18 | N/A |
| EPS Diluted Total Ops | -0.43 | -0.38 | -0.47 | -0.18 | N/A |
| EPS Diluted Continuous Ops | -0.42 | -0.37 | -0.47 | -0.18 | N/A |
| EBITDA(a) | $-944 | $362 | $-679 | $-432 | $N/A |